Ajooni Biotech Limited (AJOONI) — Cash Flow-to-Debt Ratio
Ajooni Biotech Limited (AJOONI) has a Cash Flow-to-Debt Ratio of 0.95x as of September 2025, meaning its operating cash flow of Rs135.46 Million could theoretically repay 1% of its total liabilities (Rs143.18 Million) in one year. See Ajooni Biotech Limited free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ajooni Biotech Limited Cash Flow-to-Debt Ratio (2013–2026)
Historical debt coverage capacity for Ajooni Biotech Limited across 14 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Ajooni Biotech Limited.
Annual Cash Flow-to-Debt Ratio for Ajooni Biotech Limited (2013–2026)
Year-by-year debt coverage analysis for Ajooni Biotech Limited. Check Ajooni Biotech Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.18x | Rs-52.03 Million | Rs291.74 Million | ▲ +93.0% |
| 2025 | -2.54x | Rs-177.37 Million | Rs69.72 Million | ▼ -209.7% |
| 2024 | -0.82x | Rs-39.52 Million | Rs48.12 Million | ▼ -151.2% |
| 2023 | -0.33x | Rs-55.79 Million | Rs170.62 Million | ▼ -212.2% |
| 2022 | 0.29x | Rs36.84 Million | Rs126.35 Million | ▲ +212.2% |
| 2021 | 0.09x | Rs11.56 Million | Rs123.76 Million | ▲ +115.3% |
| 2020 | -0.61x | Rs-43.85 Million | Rs71.76 Million | ▲ +24.4% |
| 2019 | -0.81x | Rs-49.19 Million | Rs60.85 Million | ▼ -13265151475.7% |
| 2018 | 0.00x | Rs-0.51 | Rs83.70 Million | ▲ +100.0% |
| 2017 | -0.06x | Rs-6.69 Million | Rs118.86 Million | ▲ +82.6% |
| 2016 | -0.32x | Rs-6.15 Million | Rs19.06 Million | ▼ -330.1% |
| 2015 | 0.14x | Rs1.67 Million | Rs11.88 Million | ▲ +114.2% |
| 2014 | -0.99x | Rs-1.45 Million | Rs1.46 Million | ▲ +80.2% |
| 2013 | -5.00x | Rs-10.00K | Rs2.00K | — |